Meghan Fitzgerald sold $1.9M of Roivant Sciences (ROIV)

Executed Mar 26, disclosed Mar 30, 4 days later.

Value, as filed

$1.9M

70,000 sh × $27.45

Executed

Mar 26

the trade date, as filed

Disclosed

Mar 30

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Meghan Fitzgerald Director profile →

Meghan Fitzgerald (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $1.9M of ROIV (70,000 sh × $27.45, as filed), executed Mar 26.

The name

ROIV

Roivant Sciences Ltd. ROIV · Healthcare · 75 filings in 24 months ticker →

Healthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Meghan Fitzgerald in ROIV

ROIVSALE Roivant Sciences Ltd. $187K
4,712 sh × $39.68
Exec Sep 15
Filed Sep 17 · 6:42 PM ET ROIVSALE Roivant Sciences Ltd. $798K
20,000 sh × $39.90
Exec Sep 8
Filed Sep 10 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. $349K
10,000 sh × $34.90
Exec Jun 30
Filed Jul 2 · 7:03 PM ET